AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 80 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,943,000 | – | 375,000 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $20,000 | 0.01% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 64,390 | $10,000 | 0.00% |
| Verity Asset Management, Inc. | 17,000 | $3,000 | 0.00% |
| VANGUARD GROUP INC | 1,252,050 | $201,000 | 0.00% |
| Kistler-Tiffany Companies, LLC | 690 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 2 | $0 | 0.00% |
| BARCLAYS PLC | 69 | $0 | 0.00% |
| OneDigital Investment Advisors LLC | 31,110 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,365 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 15,384 | $2,000 | 0.00% |